Which statement best describes stage concordance between clinical and pathologic staging?

Which statement best describes stage concordance between clinical and pathologic staging?

• A. Stage data is always identical between clinical and pathologic
• B. Discordance is not possible
• C. Differences between clinical and pathologic stage can cause discordance and affect data quality
• D. Discordance only affects mortality data

Answer: (C)

The question tests how staging data from different sources can align or diverge and why that matters for data quality. Clinical stage is assigned based on exams, imaging, and biopsies before any treatment. Pathologic stage comes from microscopic examination of tissue after surgery. Because these assessments rely on different information and occur at different times, they can match or differ. When they don’t match, that’s discordance, and it matters because stage is a key variable used to estimate prognosis, guide treatment decisions, and compare outcomes across groups. If discordance occurs, it can lead to misclassification, bias stage-specific survival or incidence analyses, and generally reduce the reliability of registry data. Pathologic staging is usually more accurate when available, but factors like neoadjuvant therapy or sampling limits can cause discrepancies. Therefore, differences between clinical and pathologic stage can cause discordance and affect data quality.

The question tests how staging data from different sources can align or diverge and why that matters for data quality. Clinical stage is assigned based on exams, imaging, and biopsies before any treatment. Pathologic stage comes from microscopic examination of tissue after surgery. Because these assessments rely on different information and occur at different times, they can match or differ. When they don’t match, that’s discordance, and it matters because stage is a key variable used to estimate prognosis, guide treatment decisions, and compare outcomes across groups. If discordance occurs, it can lead to misclassification, bias stage-specific survival or incidence analyses, and generally reduce the reliability of registry data. Pathologic staging is usually more accurate when available, but factors like neoadjuvant therapy or sampling limits can cause discrepancies. Therefore, differences between clinical and pathologic stage can cause discordance and affect data quality.